Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Vir Biotechnology Inc’s stock clocked out at $5.43, up 6.26% from its previous closing price of $5.11. In other words, the price has increased by $6.26 from its previous closing price. On the day, 1.39 million shares were traded. VIR stock price reached its highest trading level at $5.44 during the session, while it also had its lowest trading level at $5.015.
Ratios:
To gain a deeper understanding of VIR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.79 and its Current Ratio is at 6.79. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when SATO VICKI L sold 22,000 shares for $5.10 per share. The transaction valued at 112,207 led to the insider holds 1,298,391 shares of the business.
VICKI LEE SATO bought 66,000 shares of VIR for $332,640 on Jul 01 ’25. On Jun 11 ’25, another insider, GEORGE SCANGOS, who serves as the Former Director of the company, bought 19,957 shares for $5.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 750632320 and an Enterprise Value of -8847465. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.98 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at -0.424 whereas that against EBITDA is 0.016.
Stock Price History:
The Beta on a monthly basis for VIR is 1.18, which has changed by -0.36342323 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is 2.93%, while the 200-Day Moving Average is calculated to be -26.29%.
Shares Statistics:
It appears that VIR traded 1.31M shares on average per day over the past three months and 1244530 shares per day over the past ten days. A total of 138.06M shares are outstanding, with a floating share count of 89.08M. Insiders hold about 35.56% of the company’s shares, while institutions hold 53.56% stake in the company. Shares short for VIR as of 1749772800 were 11367540 with a Short Ratio of 8.71, compared to 1747267200 on 10942673. Therefore, it implies a Short% of Shares Outstanding of 11367540 and a Short% of Float of 13.29.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
